Free Trial

HB Wealth Management LLC Buys 5,796 Shares of Becton, Dickinson and Company (NYSE:BDX)

Becton, Dickinson and Company logo with Medical background

Key Points

  • HB Wealth Management LLC increased its stake in Becton, Dickinson and Company by 26.8%, acquiring an additional 5,796 shares, totaling 27,445 shares valued at $6.29 million as of the most recent reporting period.
  • Becton, Dickinson and Company recently declared a quarterly dividend of $1.04, amounting to an annualized dividend yield of 2.24%, with the ex-dividend date set for September 8th.
  • Analysts have downgraded their ratings for Becton, Dickinson and Company, with Bank of America and Goldman Sachs lowering their targets, resulting in an average target price of $219.22 with a consensus rating of "Hold."
  • Five stocks we like better than Becton, Dickinson and Company.

HB Wealth Management LLC increased its position in Becton, Dickinson and Company (NYSE:BDX - Free Report) by 26.8% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 27,445 shares of the medical instruments supplier's stock after acquiring an additional 5,796 shares during the quarter. HB Wealth Management LLC's holdings in Becton, Dickinson and Company were worth $6,287,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Northcape Wealth Management LLC boosted its holdings in Becton, Dickinson and Company by 0.5% in the 1st quarter. Northcape Wealth Management LLC now owns 9,814 shares of the medical instruments supplier's stock valued at $2,248,000 after purchasing an additional 51 shares during the period. Alpha Omega Wealth Management LLC boosted its stake in Becton, Dickinson and Company by 5.7% during the first quarter. Alpha Omega Wealth Management LLC now owns 984 shares of the medical instruments supplier's stock valued at $225,000 after buying an additional 53 shares during the period. Brady Family Wealth LLC boosted its stake in Becton, Dickinson and Company by 1.2% during the first quarter. Brady Family Wealth LLC now owns 4,317 shares of the medical instruments supplier's stock valued at $989,000 after buying an additional 53 shares during the period. Diversified Trust Co boosted its position in shares of Becton, Dickinson and Company by 4.7% during the 1st quarter. Diversified Trust Co now owns 1,188 shares of the medical instruments supplier's stock valued at $272,000 after acquiring an additional 53 shares during the last quarter. Finally, REAP Financial Group LLC boosted its position in shares of Becton, Dickinson and Company by 75.3% during the 4th quarter. REAP Financial Group LLC now owns 128 shares of the medical instruments supplier's stock valued at $29,000 after acquiring an additional 55 shares during the last quarter. 86.97% of the stock is currently owned by institutional investors.

Becton, Dickinson and Company Trading Down 0.1%

Becton, Dickinson and Company stock traded down $0.17 during mid-day trading on Wednesday, hitting $182.21. The company's stock had a trading volume of 477,460 shares, compared to its average volume of 2,613,490. Becton, Dickinson and Company has a 12 month low of $163.33 and a 12 month high of $251.99. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.13 and a quick ratio of 0.64. The business has a 50 day moving average price of $174.54 and a 200-day moving average price of $201.82. The stock has a market cap of $52.22 billion, a price-to-earnings ratio of 34.76, a price-to-earnings-growth ratio of 1.38 and a beta of 0.25.

Becton, Dickinson and Company (NYSE:BDX - Get Free Report) last released its earnings results on Thursday, May 1st. The medical instruments supplier reported $3.35 earnings per share for the quarter, beating analysts' consensus estimates of $3.28 by $0.07. Becton, Dickinson and Company had a return on equity of 15.99% and a net margin of 7.28%. The company had revenue of $5.27 billion during the quarter, compared to analyst estimates of $5.35 billion. During the same quarter in the previous year, the company posted $3.17 EPS. Becton, Dickinson and Company's revenue for the quarter was up 4.5% on a year-over-year basis. As a group, analysts forecast that Becton, Dickinson and Company will post 14.43 EPS for the current year.

Becton, Dickinson and Company Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Monday, September 8th will be paid a dividend of $1.04 per share. This represents a $4.16 annualized dividend and a dividend yield of 2.28%. The ex-dividend date of this dividend is Monday, September 8th. Becton, Dickinson and Company's dividend payout ratio (DPR) is 79.39%.

Insider Activity

In other news, EVP David Shan sold 1,166 shares of the company's stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $171.19, for a total transaction of $199,607.54. Following the completion of the transaction, the executive vice president directly owned 4,575 shares of the company's stock, valued at approximately $783,194.25. This represents a 20.31% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Michael David Garrison sold 1,185 shares of the company's stock in a transaction that occurred on Friday, July 18th. The shares were sold at an average price of $180.29, for a total value of $213,643.65. Following the transaction, the executive vice president directly owned 4,887 shares of the company's stock, valued at $881,077.23. The trade was a 19.52% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.36% of the company's stock.

Analyst Upgrades and Downgrades

BDX has been the subject of a number of research analyst reports. Stifel Nicolaus dropped their price target on Becton, Dickinson and Company from $280.00 to $224.00 and set a "buy" rating for the company in a research report on Friday, May 2nd. Wall Street Zen lowered shares of Becton, Dickinson and Company from a "buy" rating to a "hold" rating in a research report on Friday, May 2nd. Citigroup lowered shares of Becton, Dickinson and Company from a "strong-buy" rating to a "hold" rating and dropped their target price for the company from $217.00 to $185.00 in a research report on Thursday, May 22nd. Piper Sandler lowered shares of Becton, Dickinson and Company from an "overweight" rating to a "neutral" rating and cut their target price for the stock from $260.00 to $185.00 in a research report on Friday, May 2nd. Finally, Raymond James Financial lowered shares of Becton, Dickinson and Company from an "outperform" rating to a "market perform" rating in a research report on Friday, May 2nd. Eight analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $219.22.

Read Our Latest Stock Analysis on Becton, Dickinson and Company

About Becton, Dickinson and Company

(Free Report)

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.

See Also

Institutional Ownership by Quarter for Becton, Dickinson and Company (NYSE:BDX)

Should You Invest $1,000 in Becton, Dickinson and Company Right Now?

Before you consider Becton, Dickinson and Company, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Becton, Dickinson and Company wasn't on the list.

While Becton, Dickinson and Company currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines